Correlation Between Innovation1 Biotech and Novo Nordisk

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Innovation1 Biotech and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innovation1 Biotech and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Innovation1 Biotech and Novo Nordisk AS, you can compare the effects of market volatilities on Innovation1 Biotech and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innovation1 Biotech with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innovation1 Biotech and Novo Nordisk.

Diversification Opportunities for Innovation1 Biotech and Novo Nordisk

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Innovation1 and Novo is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Innovation1 Biotech and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and Innovation1 Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innovation1 Biotech are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of Innovation1 Biotech i.e., Innovation1 Biotech and Novo Nordisk go up and down completely randomly.

Pair Corralation between Innovation1 Biotech and Novo Nordisk

If you would invest  0.10  in Innovation1 Biotech on October 11, 2024 and sell it today you would earn a total of  0.00  from holding Innovation1 Biotech or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy95.24%
ValuesDaily Returns

Innovation1 Biotech  vs.  Novo Nordisk AS

 Performance 
       Timeline  
Innovation1 Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Innovation1 Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental drivers, Innovation1 Biotech is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.
Novo Nordisk AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Innovation1 Biotech and Novo Nordisk Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Innovation1 Biotech and Novo Nordisk

The main advantage of trading using opposite Innovation1 Biotech and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innovation1 Biotech position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.
The idea behind Innovation1 Biotech and Novo Nordisk AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios